The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility
Open accessAbstract
Background— Sildenafil was recently approved for the treatment of pulmonary arterial hypertension. The beneficial effects of phosphodiesterase type 5 (PDE5) inhibitors in pulmonary arterial hypertension are thought to result from relatively selective vasodilatory and antiproliferative effects on the pulmonary vasculature and, on the basis of early data showing lack of significant PDE5 expression in the normal heart, are thought to spare the myocardium. Methods and Results— We studied surgical specimens from 9 patients and show here for the first time that although PDE5 is not expressed in the myocardium of the normal human right ventricle (RV), mRNA and protein are markedly upregulated in hypertrophied RV (RVH) myocardium. PDE5 also is upregulated in rat RVH. PDE5 inhibition (with either MY-5445 or sildenafil) significantly increases contractility, measured in the perfused heart (modified Langendorff preparation) and isolated cardiomyocytes, in RVH but not normal RV. PDE5 inhibition leads to increases in both cGMP and cAMP in RVH but not normal RV. Protein kinase G activity is suppressed in RVH, explaining why the PDE5 inhibitor–induced increase in cGMP does not lead to inhibition of contractility. Rather, it leads to inhibition of the cGMP-sensitive PDE3, explaining the increase in cAMP and contractility. This is further supported by our findings that, in RVH protein kinase A, inhibition completely inhibits PDE5-induced inotropy, whereas protein kinase G inhibition does not. Conclusions— The ability of PDE5 inhibitors to increase RV inotropy and to decrease RV afterload without significantly affecting systemic hemodynamics makes them ideal for the treatment of diseases affecting the RV, including pulmonary arterial hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Voelkel, N. F., Quaife, R. A., Leinwand, L. A., Barst, R. J., McGoon, M. D., Meldrum, D. R., Dupuis, J., Long, C. S., Rubin, L. J., Smart, F. W., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.632208 · Cited by 1,250
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Michelakis, E., Tymchak, W., Lien, D., Webster, L., Hashimoto, K., & Archer, S. (2002) · Circulation · doi:10.1161/01.cir.0000016641.12984.dc · Cited by 577
Self-citationDiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R. C., & Wright, R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201101 · Cited by 550
Wallis, R. M., Corbin, J. D., Francis, S. H., & Ellis, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00042-9 · Cited by 504
McMurtry, M. S., Bonnet, S., Wu, X., Dyck, J. R. B., Haromy, A., Hashimoto, K., & Michelakis, E. D. (2004) · Circulation Research · doi:10.1161/01.res.0000145360.16770.9f · Cited by 453
Self-citationUse of sildenafil (Viagra) in patients with cardiovascular disease
Cheitlin, M. D., Hutter, A. M., Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O., Zusman, R. M., Forrester, J. S., Douglas, P. S., Faxon, D. P., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00656-1 · Cited by 450
The right ventricle in pulmonary hypertension
Chin, K. M., Kim, N. H. S., & Rubin, L. J. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200502000-00003 · Cited by 429
Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)
Degerman, E., Belfrage, P., & Manganiello, V. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6823 · Cited by 428
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
Pfeifer, A., Aszódi, A., Seidler, U., Ruth, P., Hofmann, F., & Fässler, R. (1996) · Science · doi:10.1126/science.274.5295.2082 · Cited by 403
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study
Wilkins, M. R., Paul, G. A., Strange, J. W., Tunariu, N., Gin-Sing, W., Banya, W. A., Westwood, M. A., Stefanidis, A., Ng, L. L., Pennell, D. J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1411oc · Cited by 380
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
Cowan, K. N., Heilbut, A., Humpl, T., Lam, C., Ito, S., & Rabinovitch, M. (2000) · Nature Medicine · doi:10.1038/76282 · Cited by 378
Right Ventricular Myocardium Derives From the Anterior Heart Field
Zaffran, S., Kelly, R. G., Meilhac, S. M., Buckingham, M. E., & Brown, N. A. (2004) · Circulation Research · doi:10.1161/01.res.0000136815.73623.be · Cited by 378
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
Wharton, J., Strange, J. W., Møller, G. M. O., Growcott, E. J., Ren, X., Franklyn, A. P., Phillips, S. C., & Wilkins, M. R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1587oc · Cited by 371
Effects of sildenafil citrate on human hemodynamics
Jackson, G., Benjamin, N., Jackson, N., & Allen, M. J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00043-0 · Cited by 368
McMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 368
Hemodynamic Effects of Sildenafil in Men with Severe Coronary Artery Disease
Herrmann, H. C., Chang, G., Klugherz, B. D., & Mahoney, P. D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422201 · Cited by 287
Ghofrani, H. A., Voswinckel, R., Reichenberger, F., Olschewski, H., Haredza, P., Karadaş, B., Schermuly, R. T., Weissmann, N., Seeger, W., & Grimminger, F. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.060 · Cited by 286
A Stimulatory Role for cGMP-Dependent Protein Kinase in Platelet Activation
Li, Z., Xi, X., Gu, M., Feil, R., Ye, R. D., Eigenthaler, M., Hofmann, F., & Du, X. (2003) · Cell · doi:10.1016/s0092-8674(02)01254-0 · Cited by 265
SENZAKI, H., SMITH, C. J., JUANG, G. J., ISODA, T., MAYER, S. P., OHLER, A., PAOLOCCI, N., TOMASELLI, G. F., HARE, J. M., & KASS, D. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0538com · Cited by 228
Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
Hasegawa, K., Fujiwara, H., Doyama, K., Miyamae, M., Fujiwara, T., Suga, S., Mukoyama, M., Nakao, K., Imura, H., & Sasayama, S. (1993) · Circulation · doi:10.1161/01.cir.88.2.372 · Cited by 213
HEMODYNAMIC EFFECTS OF SILDENAFIL IN MEN WITH SEVERE CORONARY ARTERY DISEASE
Errmann, C. H., Hang, G. E. C., Lugherz, D. K., & Ahoney, P. A. D. M. (2000) · Cited by 194
Sildenafil Inhibits β-Adrenergic–Stimulated Cardiac Contractility in Humans
Borlaug, B. A., Melenovsky, V., Marhin, T., Fitzgerald, P., & Kass, D. A. (2005) · Circulation · doi:10.1161/circulationaha.105.540500 · Cited by 169
Sympathetic Activation by Sildenafil
Phillips, B. G., Kato, M., Pesek, C. A., Winnicki, M., Narkiewicz, K., Davison, D. E., & Somers, V. K. (2000) · Circulation · doi:10.1161/01.cir.102.25.3068 · Cited by 123
Role of sodium‐calcium exchange in activation of contraction in rat ventricle.
Bouchard, R. A., Clark, R. B., & Giles, W. R. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019953 · Cited by 101
Webster, L., Michelakis, E. D., Davis, T. M. A., & Archer, S. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.5.514 · Cited by 86
Self-citationSildenafil citrate does not affect cardiac contractility in human or dog heart
Corbin, J. D., Rannels, S. R., Neal, D. W., Chang, P., Grimes, K. A., Beasley, A., & Francis, S. H. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125002522 · Cited by 66
Hagiwara, M., Endo, T., Kanayama, T., & Hidaka, H. (1984) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21767-0 · Cited by 49
Cremers, B., Scheler, M., Maack, C., Wendler, O., Schäfers, H., Südkamp, M., & Böhm, M. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200305000-00010 · Cited by 43
Hypothyroidism Decreases the ATP Sensitivity of K ATP Channels from Rat Heart
Light, P. E., Harbison, S. P., Giles, W. R., & French, R. J. (1998) · The Journal of Membrane Biology · doi:10.1007/s002329900359 · Cited by 33
Self-citationSu, J., Zhang, Q., Moalem, J., Tse, J., Scholz, P., & Weiss, H. R. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00880.2004 · Cited by 22
Cited by
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,341
Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., et al. (2013) · JAMA · doi:10.1001/jama.2013.2024 · Cited by 1,155
Diagnosis and Assessment of Pulmonary Arterial Hypertension
Badesch, D. B., Champion, H. C., Gomez Sanchez, M. A., Hoeper, M. M., Loyd, J. E., Manes, A., McGoon, M., Naeije, R., Olschewski, H., Oudiz, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.011 · Cited by 1,138
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Self-citationRight Heart Adaptation to Pulmonary Arterial Hypertension
Vonk-Noordegraaf, A., Haddad, F., Chin, K. M., Forfia, P. R., Kawut, S. M., Lumens, J., Naeije, R., Newman, J., Oudiz, R. J., Provencher, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.027 · Cited by 982
Metadata
- Authors
- Nagendran, J., Archer, S. L., Soliman, D., Gurtu, V., Moudgil, R., Haromy, A., St. Aubin, C., Webster, L., Rebeyka, I. M., Ross, D. B., Light, P. E., Dyck, J. R. B., & Michelakis, E. D.
- Venue
- Circulation
- Published
- 2007-07-17
- Volume
- 116
- Issue
- 3
- Pages
- 238-248
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2014500068
- Cited by
- 530
- References
- 32
- FWCI
- 12.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.